Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice.
about
The immunology of influenza virus-associated bacterial pneumoniaPostviral Complications: Bacterial PneumoniaInfluenza-associated bacterial pneumonia; managing and controlling infection on two fronts.Novel pandemic influenza A (H1N1) and community-associated methicillin-resistant Staphylococcus aureus pneumonia.Exogenous Activation of Invariant Natural Killer T Cells by α-Galactosylceramide Reduces Pneumococcal Outgrowth and Dissemination PostinfluenzaFemale resistance to pneumonia identifies lung macrophage nitric oxide synthase-3 as a therapeutic targetNox2-derived oxidative stress results in inefficacy of antibiotics against post-influenza S. aureus pneumonia.Influenza A Virus Infection Predisposes Hosts to Secondary Infection with Different Streptococcus pneumoniae Serotypes with Similar Outcome but Serotype-Specific Manifestation.Quantifying the therapeutic requirements and potential for combination therapy to prevent bacterial coinfection during influenza.The role of influenza in the severity and transmission of respiratory bacterial diseaseInhibition of Phosphodiesterase-4 during Pneumococcal Pneumonia Reduces Inflammation and Lung Injury in Mice.Adjunctive Corticosteroid Treatment Against Yersinia pestis Improves Bacterial Clearance, Immunopathology, and Survival in the Mouse Model of Bubonic Plague.In-vivo monitoring of infectious diseases in living animals using bioluminescence imaging.CXCR1/2 Antagonism Is Protective during Influenza and Post-Influenza Pneumococcal Infection.
P2860
Q28084679-FC7DDD13-3130-42D7-B774-8FDB94C3149AQ29248089-C9F135D2-A934-4F75-845E-7EC7CF978E22Q30368552-3037C0B5-29A2-4E17-8A27-0473B4D3286CQ30370676-7B08D41C-27F5-44D4-A27B-6F2B755DE344Q30394781-89BA8ACE-2490-4697-B3DA-3A3151D71D20Q34432608-B4F2992C-C2F4-410F-8294-CD9A5B396B13Q37197883-423CE9B2-CE98-4BBC-95A7-6BC3D9AC3227Q37424992-356BF1EE-8921-49F0-B85B-F9A041DCA1E8Q37733491-2CD7258D-C591-4389-A44D-857D82CE0572Q38240678-43E325A6-2797-402D-AF09-FFE1D9E47A6AQ40201663-EBBF85A5-7886-45FE-BCF9-CFAF5CC70AC1Q40617446-FD958FC5-2C66-444A-B377-1DCCE731D025Q41928242-BE0AEE6F-CF30-434D-8EB9-F149DC8FB631Q47554827-F3DB5A67-1A8C-47C5-8116-F020242FC58B
P2860
Adjunctive corticosteroid therapy improves lung immunopathology and survival during severe secondary pneumococcal pneumonia in mice.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年論文
@yue
2013年論文
@zh-hant
2013年論文
@zh-hk
2013年論文
@zh-mo
2013年論文
@zh-tw
2013年论文
@wuu
2013年论文
@zh
2013年论文
@zh-cn
name
Adjunctive corticosteroid ther ...... neumococcal pneumonia in mice.
@en
Adjunctive corticosteroid ther ...... neumococcal pneumonia in mice.
@nl
type
label
Adjunctive corticosteroid ther ...... neumococcal pneumonia in mice.
@en
Adjunctive corticosteroid ther ...... neumococcal pneumonia in mice.
@nl
prefLabel
Adjunctive corticosteroid ther ...... neumococcal pneumonia in mice.
@en
Adjunctive corticosteroid ther ...... neumococcal pneumonia in mice.
@nl
P2860
P356
P1476
Adjunctive corticosteroid ther ...... neumococcal pneumonia in mice.
@en
P2093
Hazem E Ghoneim
P2860
P304
P356
10.1093/INFDIS/JIT653
P407
P577
2013-11-23T00:00:00Z